Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
BRAND NAME: RYBELSUS (semaglutide)
Pregnancy outcomes Semaglutide pretreatment was associated with a trend toward lower pregnancy rates across all BMI subgroups compared to matched controls, although the statistical significance of these reductions varied by group (Fig
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Side effect management strategies backed by clinical data
US$ 28.99
US$ 28.47
US$ 29.25
